Report Overview

United States Defibrillator Market – Industry Trends & Forecast Report, 2030

United States Defibrillator Market size by value was estimated at USD 2.95 billion in 2023. During the forecast period between 2024 and 2030, United States Defibrillator Market size is expected to expand at a CAGR of 7.90% reaching a value of USD 4.92 billion by 2030. United States Defibrillator Market is driven by several key factors, including increasing prevalence of cardiovascular diseases and the growing geriatric population. Technological advancements, such as the development of automated external defibrillators (AEDs) and wearable defibrillators, enhance market growth. Additionally, supportive government policies and healthcare initiatives, along with rising awareness about cardiac health and emergency response, further propel the market. These factors collectively contribute to the expanding defibrillator market in United States.

Defibrillators – Overview

A defibrillator is a medical device that delivers an electric shock to the heart to restore a normal rhythm in cases of life-threatening arrhythmias, such as ventricular fibrillation or ventricular tachycardia. There are various types, including automated external defibrillators (AEDs), wearable cardioverter defibrillators, and implantable cardioverter defibrillators. These devices are crucial in emergency situations, such as sudden cardiac arrest, and can be used by both healthcare professionals and trained laypersons.

United States Defibrillator Market      

Growth Drivers

Rising Prevalence of Cardiovascular Diseases

Increasing prevalence of cardiovascular diseases (CVDs) is a major growth driver for United States Defibrillator Market. With CVDs being the leading cause of death in the United States, the demand for defibrillators, especially automated external defibrillators (AEDs) and implantable cardioverter defibrillators (ICDs), is rising. This trend is further fueled by the aging population, which is more susceptible to heart conditions, and the growing awareness of the importance of timely defibrillation.

Challenges

Reimbursement Challenges

Reimbursement challenges significantly restrain United States Defibrillator Market. Variability in reimbursement policies across states and healthcare providers creates uncertainty and limits access to these life-saving devices. High costs associated with defibrillators, coupled with inconsistent insurance coverage, deter both healthcare facilities and patients from adopting advanced defibrillator technologies. This financial barrier hampers market growth and restricts the widespread use of defibrillators, particularly in underfunded healthcare settings.

Impact of Escalating Geopolitical Tensions on United States Defibrillator Market    

Intensifying and further spreading of geopolitical tensions among countries across the regions could significantly impact United States Defibrillator Market. Supply chain disruptions, particularly for critical components sourced internationally, could lead to production delays and increased costs. Trade restrictions and tariffs may further exacerbate these issues, making it challenging for manufacturers to maintain steady supply and pricing. Additionally, economic instability resulting from geopolitical conflicts can reduce healthcare spending, affecting the procurement of defibrillators by hospitals and emergency services. These factors collectively create an uncertain market environment, potentially hindering growth and innovation in the defibrillator sector.

United States Defibrillator Market

Segmental Information

United States Defibrillator Market – By Type

By type, United States Defibrillator Market is divided into Implantable Cardioverter Defibrillators (ICD) and External Defibrillators (ED) segments. The implantable cardioverter defibrillators (ICD) segment holds a larger share of United States Defibrillator Market, due to the rising prevalence of cardiovascular diseases, the increasing adoption of ICDs for managing patients at high risk of sudden cardiac arrest, and advancements in ICD technology. ICDs are favored for their ability to deliver life-saving electrical shocks to restore normal heart rhythm. Additionally, a growing elderly population and supportive healthcare policies further contribute to the segment's significant market share.

United States Defibrillator Market – By Patient Type

Based on patient type, United States Defibrillator Market is divided into Adult and Pediatrics segments. The adult segment represents a larger share of United States Defibrillator Market by patient type, due to the higher incidence of cardiovascular diseases and sudden cardiac arrest cases among the adult population. The increasing prevalence of heart-related conditions in adults, combined with a growing awareness of life-saving devices such as defibrillators, further strengthens this segment. Additionally, healthcare initiatives and the adoption of automated external defibrillators (AEDs) in public places contribute to the segment's growth.

Competitive Landscape

Key players in the highly competitive United States Defibrillator Market include Philips, Zoll Medical, Cardiac Science, HeartSine Technologies, Powerheart, Lifespan Technologies, Defibtech, and AED Technologies. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

• In February 2024 - BIOTRONIK, a prominent company in the field of implantable medical devices, declared their decision to exclusively provide their innovative DX models for future single-chamber ICD implantations.

Scope of the Report

By Type

• Implantable Cardioverter Defibrillators (ICD)

• External Defibrillators (ED)

By Patient Type

• Adult

• Pediatrics

By End User

• Hospital

• Pre-hospital Care

• Public Access Market

• Alternate Care Facilities

• Home Healthcare

• Others

1. Research Framework
   1. Research Objective
   2. Product Overview
   3. Market Segmentation
2. Executive Summary
3. United States Defibrillator Market Insights
   1. Industry Value Chain Analysis
   2. DROC Analysis
      1. Growth Drivers
         1. Rising prevalence of cardiovascular diseases
         2. Growing geriatric population
         3. Increasing government initiatives
      2. Restraints
         1. High cost
         2. Reimbursement challenges
      3. Opportunities
         1. Rising public awareness
         2. Increasing demand for wearable cardioverter defibrillators (WCDs)
      4. Challenges
         1. User training limitations
         2. Misconceptions and fear
   3. Technological Advancements/Recent Developments
   4. Regulatory Framework
   5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
4. United States Defibrillator Market Marketing Strategies
5. United States Defibrillator Market: Pricing Analysis
6. United States Defibrillator Market Overview
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
   2. Market Share & Forecast
      1. By Type
         1. Implantable Cardioverter Defibrillators (ICD)
         2. External Defibrillators (ED)
      2. By Patient Type
         1. Adult
         2. Pediatrics
      3. By End Users
         1. Hospital
         2. Pre-hospital Care
         3. Public Access Market
         4. Alternate Care Facilities
         5. Home Healthcare
         6. Others
7. Competitive Landscape
   1. List of Key Players and Their Offerings
   2. United States Defibrillator Company Market Share Analysis, 2023
   3. Competitive Benchmarking, By Operating Parameters
   4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
8. Impact of Escalating Geopolitical Tensions on United States Defibrillator Market
9. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
   1. Philips
   2. Zoll Medical
   3. Cardiac Science
   4. HeartSine Technologies
   5. Powerheart
   6. Lifespan Technologies
   7. Defibtech
   8. AED Technologies
   9. Other Prominent Players
10. Key Strategic Recommendations
11. Research Methodology
    1.    Qualitative Research
       1.  Primary & Secondary Research
    2.    Quantitative Research
    3.    Market Breakdown & Data Triangulation
       1.  Secondary Research
       2.  Primary Research
    4.    Breakdown of Primary Research Respondents, By Country
    5.    Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

List of Figures

Figure 1       United States Defibrillator Segmentation               

Figure 2       United States Defibrillator Market Value Chain Analysis              

Figure 3       Company Market Share Analysis, 2023         

Figure 4       United States Defibrillator Market Size, By Value (USD Billion), 2019–2030             

Figure 5       United States Defibrillator Market Share, By Type, By Value, 2019–2030                 

Figure 6       United States Defibrillator Market Share, By Patient Type, By Value, 2019–2030                  

Figure 7       United States Defibrillator Market Share, By End Users, By Value, 2019–2030          

List of Tables

Table 1        United States Defibrillator Market Size, By Value (USD Billion), 2019–2030   

Table 2        United States Defibrillator Market Size, By Type, By Value, 2019–2030

Table 3        United States Defibrillator Market Size, By Patient Type, By Value, 2019–2030         

Table 4        United States Defibrillator Market Size, By End Users, By Value, 2019–2030

Table 5        Philips Company Overview

Table 6        Philips Financial Overview

Table 7        Zoll Medical Company Overview

Table 8        Zoll Medical Financial Overview

Table 9        Cardiac Science Company Overview

Table 10      Cardiac Science Financial Overview

Table 11      HeartSine Technologies Company Overview

Table 12      HeartSine Technologies Financial Overview

Table 13      Powerheart Company Overview

Table 14      Powerheart Financial Overview

Table 15      Lifespan Technologies Company Overview

Table 16      Lifespan Technologies Financial Overview

Table 17      Defibtech Company Overview

Table 18      Defibtech Financial Overview

Table 19      AED Technologies Company Overview

Table 20      AED Technologies Financial Overview